Ładuje się......
A113 TEDUGLUTIDE IN PATIENTS WITH ACTIVE CROHN’S DISEASE AND SHORT BOWEL SYNDROME
BACKGROUND: Patients with Crohn’s disease (CD) are at risk of surgery due to refractory or penetrating disease, which may result in short bowel syndrome (SBS) that requires parenteral nutrition (PN). Teduglutide is a GLP2 analogue that has been approved for the treatment of SBS although there has be...
Zapisane w:
| Wydane w: | J Can Assoc Gastroenterol |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Oxford University Press
2019
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6512651/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz006.112 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|